**Core Concept**
The management of early-stage ovarian cancer, specifically ovarian serous cisadenocarcinoma, involves a multidisciplinary approach that includes surgical staging, pathological evaluation, and adjuvant therapy. The goal is to optimize survival outcomes and minimize recurrence.

**Why the Correct Answer is Right**
The correct approach for managing ovarian serous cisadenocarcinoma involves surgical staging to assess the extent of disease spread. This includes removal of the ovaries, fallopian tubes, and omentum, as well as peritoneal biopsies and lymph node sampling. The histopathological evaluation of the surgical specimen is crucial in determining the tumor stage, grade, and type. Based on these findings, adjuvant therapy may be recommended to reduce the risk of recurrence.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option does not provide a clear management plan for ovarian serous cisadenocarcinoma. Surgical staging and adjuvant therapy are essential components of management, but this option lacks specificity.

**Option B:**
This option may be relevant for benign ovarian cysts or early-stage ovarian cancer, but it does not address the need for surgical staging and adjuvant therapy in the case of ovarian serous cisadenocarcinoma.

**Option C:**
This option may be considered for advanced-stage ovarian cancer, but it does not take into account the need for surgical staging and pathological evaluation in early-stage disease.

**Option D:**
This option is nonspecific and does not provide a clear management plan for ovarian serous cisadenocarcinoma.

**Clinical Pearl / High-Yield Fact**
The FIGO (International Federation of Gynecology and Obstetrics) staging system is widely used to classify ovarian cancer, and it plays a critical role in determining the prognosis and guiding management decisions.

**Correct Answer:** C. Chemotherapy and possibly radiotherapy, based on the extent of disease and pathological findings.